» Articles » PMID: 10628886

Lifetime Suicide Risk in Major Depression: Sex and Age Determinants

Overview
Journal J Affect Disord
Date 2000 Jan 11
PMID 10628886
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent work has demonstrated that the lifetime suicide risk for patients with DSM IV Major Depression cannot mathematically approximate the accepted figure of 15%. Gender and age significantly affect both the prevalence of major depression and suicide risk.

Methods: Gender and age stratified calculations were made on the entire population of the USA in 1994 using a mathematical algorithm. Sex specific corrections for under-reporting were incorporated into the design.

Results: The lifetime suicide risks for men and women were 7% and 1%, respectively. The combined risk was 3.4%. The male:female ratio for suicide risk in major depression was 10:1 for youths under 25, and 5.6:1 for adults.

Conclusions: Suicide in major depression is predominantly a male problem, although complacency towards female sufferers is to be avoided. Diagnosis of major depression is of limited help in predicting suicide risk compared to case specific factors. The male experience of depression that leads to suicide is often not identified as a legitimate medical complaint by either sufferers or professionals. Increasing help-accessing by males is a priority.

Clinical Implications: Patients with a history of hospitalisation; comorbidity, especially for substance abuse; and who are male, require greater vigilance for suicide risk. It may be that for males the threshold for diagnosing and treating major depression needs to be lowered.

Limitations: This research is based on a mathematical algorithm to approximate a life-long longitudinal study that identifies community cases of depression. Our findings therefore rely on the validity of the statistics used. Extrapolation is limited to populations with an actual suicide rate of 17/100,000 or less and a lifetime prevalence of major depression of 17% or more.

Citing Articles

Gender differences in the prevalence and clinical correlates of suicide attempts in young first-episode drug-naïve major depressive disorder patients with thyroid dysfunction.

Liu L, Zhou J, Song X, Luo G, Peng M, Zhang X BMC Psychiatry. 2024; 24(1):880.

PMID: 39627764 PMC: 11616182. DOI: 10.1186/s12888-024-06332-8.


Emotion-related impulsivity and suicidal ideation and behavior in schizophrenia spectrum disorder: a pilot fMRI study.

Hoptman M, Evans K, Parincu Z, Sparpana A, Sullivan E, Ahmed A Front Psychiatry. 2024; 15:1408083.

PMID: 38988737 PMC: 11234166. DOI: 10.3389/fpsyt.2024.1408083.


Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

Zaki N, Chen L, Lane R, Doherty T, Drevets W, Morrison R Neuropsychopharmacology. 2023; 48(8):1225-1233.

PMID: 37173512 PMC: 10267177. DOI: 10.1038/s41386-023-01577-5.


Is Lethality Different between Males and Females? Clinical and Gender Differences in Inpatient Suicide Attempters.

Berardelli I, Rogante E, Sarubbi S, Erbuto D, Cifrodelli M, Concolato C Int J Environ Res Public Health. 2022; 19(20).

PMID: 36293891 PMC: 9602518. DOI: 10.3390/ijerph192013309.


An observational study of acupuncture and complementary treatments for major depression: Case series from a preliminary study of proposed collaborative care model.

Tamayo S, Wei T, Chen L, Ho W, Ton G, Lee Y J Tradit Complement Med. 2022; 12(5):499-504.

PMID: 36081817 PMC: 9446101. DOI: 10.1016/j.jtcme.2022.03.002.